サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1395703

HMO（ヒトミルクオリゴ糖）の世界市場規模、シェア、産業動向分析レポート：用途別、タイプ別、濃度別、地域別展望と予測、2023年～2030年

Global Human Milk Oligosaccharides Market Size, Share & Industry Trends Analysis Report By Application, By Type (2'FL, 3'FL, 3'SL, and 6'SL), By Concentration (Neutral, and Acidic), By Regional Outlook and Forecast, 2023 - 2030

出版日
発行
KBV Research
ページ情報
英文 266 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HMO（ヒトミルクオリゴ糖）の世界市場規模、シェア、産業動向分析レポート：用途別、タイプ別、濃度別、地域別展望と予測、2023年～2030年
出版日: 2023年11月30日
発行: KBV Research
ページ情報: 英文 266 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

HMO（ヒトミルクオリゴ糖）市場規模は2030年までに10億米ドルに達すると予測され、予測期間中のCAGRは23.3%の市場成長率で上昇する見込みです。

KBV Cardinalマトリックスに掲載された分析によると、ネスレS.A.が同市場におけるトップランナーです。Abbott Laboratories社、DuPont de Nemours, Inc.社、Koninklijke DSM N.V.社などの企業は、市場における主要なイノベーターです。

市場成長要因

機能性食品としてのHMOに対する需要の増加

消費者が栄養とHMOのような特定成分の重要性について知識を深めるにつれ、その他の健康特典を提供する機能性食品への需要が増加しています。全体的な健康をサポートする製品を求める消費者の意識が市場を牽引しています。HMOは、そのプレバイオティクス特性で知られ、腸内の有益な細菌の発達を促進します。さらに、食品技術と生産方法の進歩により、HMOをより広範な食品に組み込むことが可能になっています。このことは、さまざまな嗜好に対応する革新的な機能性食品につながっています。天然で健康を促進する成分に対する消費者の嗜好は、HMO（ヒトミルクオリゴ糖）市場の全体的な拡大に寄与しています。

母乳代替物に対する需要の高まり

HMOを含む母乳は、そのユニークで複雑な栄養組成が認められています。母乳代用の需要が高まるにつれて、製造業者は母乳の栄養プロファイルを再現するために乳児用調製粉乳にHMOを組み込んでおり、粉ミルクで育てられた乳児に同様の利益を提供しています。さらに、バイオテクノロジーと生産技術の進歩は、HMOのコスト効率のよい大規模合成を可能にします。この技術的進歩により、粉ミルク製品への組み込みが容易になり、製造業者にとってより利用しやすくなり、市場成長に寄与します。母乳代替物に対する需要の高まりは、ヒトオリゴ糖の大きな市場機会を生み出しています。

市場抑制要因

HMO生産の高コスト

HMOの生産は、微生物発酵または酵素合成のような高度なバイオテクノロジー工程を伴うことが多いです。これらの複雑な方法は、専門的な設備と専門知識を必要とする場合があり、高い生産コストの一因となっています。さらに、糖類や前駆体などのHMOの生産に使用される原料は、全体的な生産コストに大きく寄与する可能性があります。これらの原料の入手可能性とコストは、大規模HMO生産の経済的実現可能性に影響を及ぼします。この制限は、様々な用途におけるHMOの広範な採用に影響を与える可能性があります。これらの要因は、今後数年間の市場成長を妨げるであろう。

用途の展望

用途に基づき、市場は乳児用調製粉乳、機能性食品及び飲食品、食品サプリメント、その他（臨床栄養及び医薬品）に細分化されます。食品サプリメント分野は、2022年の市場で大きな収益シェアを獲得しました。HMOは、消費者にこれらの有益な化合物の追加的供給源を提供するために、機能性食品や栄養補助食品に組み込まれています。これには、特定のHMOを強化したヨーグルト、グラノーラ・バーおよび飲料が含まれます。バイオテクノロジーの進歩は、制御された方法で特定のHMOを生産することを可能にします。規制機関は、様々な用途におけるこれらの化合物の安全性と有効性を評価します。

タイプの展望

タイプ別では、市場は2'FL、3'FL、3'SL、6'SLに区分されます。3'FLセグメントは、2022年のHMO（ヒトミルクオリゴ糖）市場でかなりの収益シェアを獲得しました。3'FLのプレバイオティクス特性は、乳児の多様でバランスのとれた腸内細菌叢の発達に寄与します。健康な腸内細菌叢は、消化の改善、栄養吸収の促進、病原性細菌のコロニー形成の防止など、さまざまな利点と関連しています。3'FLの健康上の利点が期待されることから、乳児用調製粉乳に配合されるケースもあります。乳児用調製粉乳メーカーは、HMOの有益な効果を含め、母乳栄養児により近い栄養プロファイルを乳児に提供するために3'FLを配合しています。

濃縮の展望

濃縮度によって、市場は中性と酸性に分類されます。酸性セグメントは、2022年の市場でかなりの収益シェアを占めました。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋およびLAMEAで分析されます。2022年には、アジア太平洋地域が市場で最大の収益シェアを占めています。この地域では、胃腸障害、糖尿病、高血圧、くる病などの慢性疾患の発生が機能性食品や飲食品の需要を高めており、これがHMO（ヒトミルクオリゴ糖）の地域市場の成長を牽引しています。さらに、インドや中国などの国々におけるベビーフードや栄養補助食品へのニーズの拡大が、今後数年間のHMO製品の需要増加に大きく貢献すると予想されます。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第4章 競合分析-世界

  • KBV Cardinal Matrix
  • 最近の業界全体の戦略的展開
    • パートナーシップ、コラボレーション、および契約
    • 製品の発売と製品の拡大
    • 買収と合併
    • 試験と承認
  • 主要成功戦略
    • 主な戦略
  • ポーターファイブフォース分析

第5章 世界のHMO（ヒトミルクオリゴ糖）市場：用途別

  • 世界の乳児用調製粉乳市場：地域別
  • 世界の機能性食品・飲料市場：地域別
  • 世界の栄養補助食品市場：地域別
  • 世界のその他（臨床栄養および医薬品）市場：地域別

第6章 世界のHMO（ヒトミルクオリゴ糖）市場：タイプ別

  • 世界の2'FL市場：地域別
  • 世界の3'FL市場：地域別
  • 世界の3'SL市場：地域別
  • 世界の6'SL市場：地域別

第7章 世界のHMO（ヒトミルクオリゴ糖）市場：濃度別

  • 世界の中性市場：地域別
  • 世界の酸性市場：地域別

第8章 世界のHMO（ヒトミルクオリゴ糖）市場：地域別

  • 北米の市場
  • 欧州の市場
  • アジア太平洋の市場
  • ラテンアメリカ・中東・アフリカの市場

第9章 企業プロファイル

  • Inbiose NV
  • Biosynth AG
  • Dextra Laboratories Ltd（ICE Sp.A）
  • Koninklijke DSM NV
  • BASF SE
  • Chr Hansen Holding A/S
  • DuPont de Nemours, Inc
  • Nestle SA
  • Abbott Laboratories
  • Royal FrieslandCampina NV

第10章 市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 2 Global Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 3 Partnerships, Collaborations and Agreements- Human Milk Oligosaccharides Market
  • TABLE 4 Product Launches And Product Expansions- Human Milk Oligosaccharides Market
  • TABLE 5 Acquisition and Mergers- Human Milk Oligosaccharides Market
  • TABLE 6 Trials and Approvals- Human Milk Oligosaccharides Market
  • TABLE 7 Global Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 8 Global Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 9 Global Infant Formula Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 10 Global Infant Formula Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 11 Global Functional Food & Beverages Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 12 Global Functional Food & Beverages Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 13 Global Food Supplements Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 14 Global Food Supplements Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 15 Global Others (Clinical Nutrition & Pharmaceuticals) Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 16 Global Others (Clinical Nutrition & Pharmaceuticals) Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 17 Global Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 18 Global Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 19 Global 2'FL Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 20 Global 2'FL Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 21 Global 3'FL Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 22 Global 3'FL Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 23 Global 3'SL Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 24 Global 3'SL Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 25 Global 6'SL Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 26 Global 6'SL Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 27 Global Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 28 Global Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 29 Global Neutral Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 30 Global Neutral Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 31 Global Acidic Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 32 Global Acidic Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 33 Global Human Milk Oligosaccharides Market, by Region, 2019 - 2022, USD Thousand
  • TABLE 34 Global Human Milk Oligosaccharides Market, by Region, 2023 - 2030, USD Thousand
  • TABLE 35 North America Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 36 North America Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 37 North America Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 38 North America Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 39 North America Infant Formula Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 40 North America Infant Formula Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 41 North America Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 42 North America Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 43 North America Food Supplements Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 44 North America Food Supplements Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 45 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 46 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 47 North America Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 48 North America Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 49 North America 2'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 50 North America 2'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 51 North America 3'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 52 North America 3'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 53 North America 3'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 54 North America 3'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 55 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 56 North America 6'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 57 North America Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 58 North America Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 59 North America Neutral Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 60 North America Neutral Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 61 North America Acidic Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 62 North America Acidic Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 63 North America Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 64 North America Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 65 US Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 66 US Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 67 US Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 68 US Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 69 US Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 70 US Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 71 US Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 72 US Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 73 Canada Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 74 Canada Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 75 Canada Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 76 Canada Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 77 Canada Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 78 Canada Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 79 Canada Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 80 Canada Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 81 Mexico Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 82 Mexico Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 83 Mexico Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 84 Mexico Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 85 Mexico Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 86 Mexico Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 87 Mexico Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 88 Mexico Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 89 Rest of North America Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 90 Rest of North America Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 91 Rest of North America Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 92 Rest of North America Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 93 Rest of North America Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 94 Rest of North America Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 95 Rest of North America Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 96 Rest of North America Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 97 Europe Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 98 Europe Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 99 Europe Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 100 Europe Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 101 Europe Infant Formula Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 102 Europe Infant Formula Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 103 Europe Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 104 Europe Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 105 Europe Food Supplements Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 106 Europe Food Supplements Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 107 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 108 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 109 Europe Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 110 Europe Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 111 Europe 2'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 112 Europe 2'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 113 Europe 3'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 114 Europe 3'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 115 Europe 3'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 116 Europe 3'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 117 Europe 6'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 118 Europe 6'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 119 Europe Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 120 Europe Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 121 Europe Neutral Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 122 Europe Neutral Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 123 Europe Acidic Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 124 Europe Acidic Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 125 Europe Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 126 Europe Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 127 Germany Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 128 Germany Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 129 Germany Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 130 Germany Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 131 Germany Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 132 Germany Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 133 Germany Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 134 Germany Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 135 UK Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 136 UK Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 137 UK Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 138 UK Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 139 UK Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 140 UK Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 141 UK Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 142 UK Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 143 France Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 144 France Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 145 France Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 146 France Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 147 France Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 148 France Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 149 France Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 150 France Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 151 Russia Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 152 Russia Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 153 Russia Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 154 Russia Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 155 Russia Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 156 Russia Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 157 Russia Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 158 Russia Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 159 Spain Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 160 Spain Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 161 Spain Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 162 Spain Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 163 Spain Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 164 Spain Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 165 Spain Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 166 Spain Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 167 Italy Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 168 Italy Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 169 Italy Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 170 Italy Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 171 Italy Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 172 Italy Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 173 Italy Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 174 Italy Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 175 Rest of Europe Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 176 Rest of Europe Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 177 Rest of Europe Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 178 Rest of Europe Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 179 Rest of Europe Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 180 Rest of Europe Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 181 Rest of Europe Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 182 Rest of Europe Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 183 Asia Pacific Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 184 Asia Pacific Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 185 Asia Pacific Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 186 Asia Pacific Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 187 Asia Pacific Infant Formula Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 188 Asia Pacific Infant Formula Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 189 Asia Pacific Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 190 Asia Pacific Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 191 Asia Pacific Food Supplements Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 192 Asia Pacific Food Supplements Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 193 Asia Pacific Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 194 Asia Pacific Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 195 Asia Pacific Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 196 Asia Pacific Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 197 Asia Pacific 2'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 198 Asia Pacific 2'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 199 Asia Pacific 3'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 200 Asia Pacific 3'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 201 Asia Pacific 3'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 202 Asia Pacific 3'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 203 Asia Pacific 6'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 204 Asia Pacific 6'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 205 Asia Pacific Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 206 Asia Pacific Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 207 Asia Pacific Neutral Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 208 Asia Pacific Neutral Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 209 Asia Pacific Acidic Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 210 Asia Pacific Acidic Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 211 Asia Pacific Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 212 Asia Pacific Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 213 China Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 214 China Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 215 China Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 216 China Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 217 China Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 218 China Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 219 China Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 220 China Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 221 Japan Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 222 Japan Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 223 Japan Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 224 Japan Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 225 Japan Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 226 Japan Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 227 Japan Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 228 Japan Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 229 India Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 230 India Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 231 India Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 232 India Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 233 India Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 234 India Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 235 India Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 236 India Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 237 South Korea Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 238 South Korea Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 239 South Korea Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 240 South Korea Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 241 South Korea Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 242 South Korea Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 243 South Korea Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 244 South Korea Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 245 Australia & New Zealand Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 246 Australia & New Zealand Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 247 Australia & New Zealand Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 248 Australia & New Zealand Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 249 Australia & New Zealand Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 250 Australia & New Zealand Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 251 Australia & New Zealand Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 252 Australia & New Zealand Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 253 Malaysia Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 254 Malaysia Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 255 Malaysia Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 256 Malaysia Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 257 Malaysia Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 258 Malaysia Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 259 Malaysia Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 260 Malaysia Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 261 Rest of Asia Pacific Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 262 Rest of Asia Pacific Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 263 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 264 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 265 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 266 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 267 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 268 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 269 LAMEA Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 270 LAMEA Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 271 LAMEA Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 272 LAMEA Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 273 LAMEA Infant Formula Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 274 LAMEA Infant Formula Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 275 LAMEA Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 276 LAMEA Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 277 LAMEA Food Supplements Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 278 LAMEA Food Supplements Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 279 LAMEA Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 280 LAMEA Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 281 LAMEA Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 282 LAMEA Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 283 LAMEA 2'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 284 LAMEA 2'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 285 LAMEA 3'FL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 286 LAMEA 3'FL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 287 LAMEA 3'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 288 LAMEA 3'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 289 LAMEA 6'SL Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 290 LAMEA 6'SL Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 291 LAMEA Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 292 LAMEA Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 293 LAMEA Neutral Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 294 LAMEA Neutral Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 295 LAMEA Acidic Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 296 LAMEA Acidic Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 297 LAMEA Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
  • TABLE 298 LAMEA Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
  • TABLE 299 Brazil Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 300 Brazil Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 301 Brazil Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 302 Brazil Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 303 Brazil Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 304 Brazil Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 305 Brazil Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 306 Brazil Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
  • TABLE 307 Argentina Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
  • TABLE 308 Argentina Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
  • TABLE 309 Argentina Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
  • TABLE 310 Argentina Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
  • TABLE 311 Argentina Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
  • TABLE 312 Argentina Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
  • TABLE 313 Argentina Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
  • TABLE 314 Argentina Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
目次

The Global Human Milk Oligosaccharides Market size is expected to reach $1 billion by 2030, rising at a market growth of 23.3% CAGR during the forecast period.

Due to the increasing demand for infant food, the proliferation of human milk oligosaccharides manufacturers, and the regulatory approval of HMOs as infant formula ingredients, Europe is anticipated to witness nearly 20% of the total market share by 2030. The United Kingdom exhibits the lowest breastfeeding rate, a circumstance that can be ascribed to diminished public health funding, inadequate knowledge regarding the health advantages of breast milk, and societal stigmas associated with public lactation. This provides the industry with a substantial opportunity to enter the market in the United Kingdom.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, in January, 2023, Royal FrieslandCampina N.V. signed a partnership with Triplebar, an American biotechnology company, to develop cell-based proteins using precision fermentation techniques. The partnership would lead to the development of innovative and future-proof protein solutions that would improve human health. Additionally, in May, 2019, BASF SE partnered with Glycosyn, a New Zealander pharmaceutical company, to develop and commercialize human milk oligosaccharides (HMOs). The partnership would advance the HMO research that would benefit the consumers in the form of improved gut health and other benefits.

Based on the Analysis presented in the KBV Cardinal matrix; Nestle S.A is the forerunner in the Market. Companies such as Abbott Laboratories, DuPont de Nemours, Inc. and Koninklijke DSM N.V. are some of the key innovators in Market. In February, 2019, DuPont de Nemours, Inc. signed a partnership with Lonza, a Swiss pharmaceutical company, to develop and commercialize its CARE4U 2'-FL, a human milk oligosaccharide. The partnership comes in line with DuPont's business growth strategy.

Market Growth Factors

Increase in demand for HMOs as functional food products

As consumers become more educated about nutrition and the importance of specific components like HMOs, there is an increased demand for functional foods that offer additional health benefits. Consumer awareness drives the market as individuals seek products that support overall well-being. HMOs are known for their prebiotic properties, promoting the development of beneficial bacteria in the gut. Additionally, advances in food technology and production methods have made incorporating HMOs into a broader range of food products feasible. This has led to innovative functional foods that cater to different tastes and preferences. Consumer preferences for natural and health-promoting ingredients contribute to the overall expansion of the human milk oligosaccharide market.

Rising demand for breast milk substitutes

Breast milk, including HMOs, is recognized for its unique and complex nutritional composition. As the demand for breast milk substitutes grows, manufacturers are incorporating HMOs into infant formulas to replicate the nutritional profile of breast milk, offering similar benefits to formula-fed infants. Additionally, advances in biotechnology and production techniques enable the cost-effective large-scale synthesis of HMOs. This technological progress facilitates their incorporation into formula products, making them more accessible to manufacturers and contributing to market growth. The rising demand for breast milk substitutes has created a significant market opportunity for human oligosaccharides.

Market Restraining Factors

High cost of HMO production

The production of HMOs often involves advanced biotechnological processes, such as microbial fermentation or enzymatic synthesis. These intricate methods may require specialized equipment and expertise, contributing to higher production costs. Moreover, The raw materials used in producing HMOs, such as sugars and precursors, can contribute significantly to the overall production costs. The availability and cost of these raw materials influence the economic feasibility of large-scale HMO production. This limitation could impact the broader adoption of HMOs in various applications. These factors will hamper the market growth in the coming years.

Application Outlook

Based on application, the market is fragmented into infant formula, functional food & beverages, food supplements, and others (clinical nutrition & pharmaceuticals). The food supplements segment garnered a significant revenue share in the market in 2022. HMOs are being incorporated into functional foods and dietary supplements to provide consumers with an additional source of these beneficial compounds. This includes yogurt, granola bars, and beverages enriched with specific HMOs. Advances in biotechnology allow for the production of specific HMOs in a controlled manner. Regulatory bodies assess the safety and efficacy of these compounds in various applications.

Type Outlook

On the basis of type, the market is segmented into 2' FL, 3'FL, 3'SL, and 6'SL. The 3'FL segment acquired a substantial revenue share in the human milk oligosaccharide market in 2022. The prebiotic properties of 3'FL contribute to developing a diverse and balanced gut microbiota in infants. A healthy gut microbiome is associated with various benefits, including improved digestion, enhanced nutrient absorption, and the prevention of pathogenic bacteria colonization. The potential health benefits of 3'FL have led to its inclusion in some infant formulas. Manufacturers are incorporating 3'FL to provide formula-fed infants with a nutritional profile closer to breastfed infants, including the beneficial effects of HMOs.

Concentration Outlook

By concentration, the market is classified into neutral and acidic. The acidic segment covered a considerable revenue share in the market in 2022. These contain acidic residues, primarily sialic acid, linked to the oligosaccharide chains. Sialic acid-containing HMOs, such as 3'-sialyl lactose (3'-SL) and 6'-sialyl lactose (6'-SL), are part of the acidic group. These acidic HMOs involve various biological functions, including supporting infants' brain development and cognitive functions.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region witnessed the largest revenue share in the market. The occurrence of chronic diseases such as gastrointestinal disorders, diabetes, hypertension, and rickets in this area is increasing the demand for functional foods and beverages, which in turn is driving the growth of the regional market for human milk oligosaccharides. Moreover, it is anticipated that the expanding need for baby food and dietary supplements in nations such as India and China will substantially contribute to the rising demand for HMO products over the next few years.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A)

Recent Strategies Deployed in Human Milk Oligosaccharides Market

Partnerships, Collaborations & Agreements

Jan-2023: Royal FrieslandCampina N.V. signed a partnership with Triplebar, an American biotechnology company, to develop cell-based proteins using precision fermentation techniques. The partnership would lead to the development of innovative and future-proof protein solutions that would improve human health.

Apr-2021: BASF SE came into partnership with NutiFood, a Vietnamese dairy company, to provide it with HMO for its nutrition products. The partnership would provide Vietnamese customers with good quality and accessible infant nutrition products.

Trials and Approvals

Oct-2023: Koninklijke DSM N.V. recieved approval from China's CSFA for its 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) human milk oligosaccharide (HMO) ingredients.

Oct-2023: Royal FrieslandCampina N.V. received approval from the Chinese Ministry of Agriculture and Rural Affairs for its 2'-Fucosyllactose (2'-FL) infant milk production stain.

Oct-2022: Royal FrieslandCampina N.V. received approval from Food Standards Australia New Zealand (FSANZ) for its Aequival 2'-Fucosyllactose (2'-FL) infant milk formula ingredient.

Jun-2022: Chr. Hansen Holding A/S received approval from Food Standards Australia New Zealand, FSANZ, for its 2'-FL human milk oligosaccharide.

Product Launches and Product Expansions

Nov-2021: Abbott Laboratories announced the launch of Similac 360 Total Care, an HMO-based infant formula. The formula comprises five different HMOs and aids immune system development in babies.

Aug-2021: Nestle S.A. released NAN SUPREME PRO 3, a formula product comprising five human milk oligosaccharides. The five HMOs in the products include 2'-FL, 6'-SL, 3'-SL, DFL, and LNT.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Infant Formula
  • Functional Food & Beverages
  • Food Supplements
  • Others (Clinical Nutrition & Pharmaceuticals)

By Type

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

By Concentration

  • Neutral
  • Acidic

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia & New Zealand
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Koninklijke DSM N.V.
  • BASF SE
  • Chr. Hansen Holding A/S
  • DuPont de Nemours, Inc.
  • Nestle S.A
  • Inbiose NV
  • Biosynth AG
  • Abbott Laboratories
  • Royal FrieslandCampina N.V.
  • Dextra Laboratories Ltd (ICE S.p.A)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Human Milk Oligosaccharides Market, by Application
    • 1.4.2 Global Human Milk Oligosaccharides Market, by Type
    • 1.4.3 Global Human Milk Oligosaccharides Market, by Concentration
    • 1.4.4 Global Human Milk Oligosaccharides Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Trials and Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.4 Porter Five Forces Analysis

Chapter 5. Global Human Milk Oligosaccharides Market, by Application

  • 5.1 Global Infant Formula Market, by Region
  • 5.2 Global Functional Food & Beverages Market, by Region
  • 5.3 Global Food Supplements Market, by Region
  • 5.4 Global Others (Clinical Nutrition & Pharmaceuticals) Market, by Region

Chapter 6. Global Human Milk Oligosaccharides Market, by Type

  • 6.1 Global 2'FL Market, by Region
  • 6.2 Global 3'FL Market, by Region
  • 6.3 Global 3'SL Market, by Region
  • 6.4 Global 6'SL Market, by Region

Chapter 7. Global Human Milk Oligosaccharides Market, by Concentration

  • 7.1 Global Neutral Market, by Region
  • 7.2 Global Acidic Market, by Region

Chapter 8. Global Human Milk Oligosaccharides Market, by Region

  • 8.1 North America Human Milk Oligosaccharides Market
    • 8.1.1 North America Human Milk Oligosaccharides Market, by Application
      • 8.1.1.1 North America Infant Formula Market, by Country
      • 8.1.1.2 North America Functional Food & Beverages Market, by Country
      • 8.1.1.3 North America Food Supplements Market, by Country
      • 8.1.1.4 North America Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
    • 8.1.2 North America Human Milk Oligosaccharides Market, by Type
      • 8.1.2.1 North America 2'FL Market, by Country
      • 8.1.2.2 North America 3'FL Market, by Country
      • 8.1.2.3 North America 3'SL Market, by Country
      • 8.1.2.4 North America 6'SL Market, by Country
    • 8.1.3 North America Human Milk Oligosaccharides Market, by Concentration
      • 8.1.3.1 North America Neutral Market, by Country
      • 8.1.3.2 North America Acidic Market, by Country
    • 8.1.4 North America Human Milk Oligosaccharides Market, by Country
      • 8.1.4.1 US Human Milk Oligosaccharides Market
        • 8.1.4.1.1 US Human Milk Oligosaccharides Market, by Application
        • 8.1.4.1.2 US Human Milk Oligosaccharides Market, by Type
        • 8.1.4.1.3 US Human Milk Oligosaccharides Market, by Concentration
      • 8.1.4.2 Canada Human Milk Oligosaccharides Market
        • 8.1.4.2.1 Canada Human Milk Oligosaccharides Market, by Application
        • 8.1.4.2.2 Canada Human Milk Oligosaccharides Market, by Type
        • 8.1.4.2.3 Canada Human Milk Oligosaccharides Market, by Concentration
      • 8.1.4.3 Mexico Human Milk Oligosaccharides Market
        • 8.1.4.3.1 Mexico Human Milk Oligosaccharides Market, by Application
        • 8.1.4.3.2 Mexico Human Milk Oligosaccharides Market, by Type
        • 8.1.4.3.3 Mexico Human Milk Oligosaccharides Market, by Concentration
      • 8.1.4.4 Rest of North America Human Milk Oligosaccharides Market
        • 8.1.4.4.1 Rest of North America Human Milk Oligosaccharides Market, by Application
        • 8.1.4.4.2 Rest of North America Human Milk Oligosaccharides Market, by Type
        • 8.1.4.4.3 Rest of North America Human Milk Oligosaccharides Market, by Concentration
  • 8.2 Europe Human Milk Oligosaccharides Market
    • 8.2.1 Europe Human Milk Oligosaccharides Market, by Application
      • 8.2.1.1 Europe Infant Formula Market, by Country
      • 8.2.1.2 Europe Functional Food & Beverages Market, by Country
      • 8.2.1.3 Europe Food Supplements Market, by Country
      • 8.2.1.4 Europe Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
    • 8.2.2 Europe Human Milk Oligosaccharides Market, by Type
      • 8.2.2.1 Europe 2'FL Market, by Country
      • 8.2.2.2 Europe 3'FL Market, by Country
      • 8.2.2.3 Europe 3'SL Market, by Country
      • 8.2.2.4 Europe 6'SL Market, by Country
    • 8.2.3 Europe Human Milk Oligosaccharides Market, by Concentration
      • 8.2.3.1 Europe Neutral Market, by Country
      • 8.2.3.2 Europe Acidic Market, by Country
    • 8.2.4 Europe Human Milk Oligosaccharides Market, by Country
      • 8.2.4.1 Germany Human Milk Oligosaccharides Market
        • 8.2.4.1.1 Germany Human Milk Oligosaccharides Market, by Application
        • 8.2.4.1.2 Germany Human Milk Oligosaccharides Market, by Type
        • 8.2.4.1.3 Germany Human Milk Oligosaccharides Market, by Concentration
      • 8.2.4.2 UK Human Milk Oligosaccharides Market
        • 8.2.4.2.1 UK Human Milk Oligosaccharides Market, by Application
        • 8.2.4.2.2 UK Human Milk Oligosaccharides Market, by Type
        • 8.2.4.2.3 UK Human Milk Oligosaccharides Market, by Concentration
      • 8.2.4.3 France Human Milk Oligosaccharides Market
        • 8.2.4.3.1 France Human Milk Oligosaccharides Market, by Application
        • 8.2.4.3.2 France Human Milk Oligosaccharides Market, by Type
        • 8.2.4.3.3 France Human Milk Oligosaccharides Market, by Concentration
      • 8.2.4.4 Russia Human Milk Oligosaccharides Market
        • 8.2.4.4.1 Russia Human Milk Oligosaccharides Market, by Application
        • 8.2.4.4.2 Russia Human Milk Oligosaccharides Market, by Type
        • 8.2.4.4.3 Russia Human Milk Oligosaccharides Market, by Concentration
      • 8.2.4.5 Spain Human Milk Oligosaccharides Market
        • 8.2.4.5.1 Spain Human Milk Oligosaccharides Market, by Application
        • 8.2.4.5.2 Spain Human Milk Oligosaccharides Market, by Type
        • 8.2.4.5.3 Spain Human Milk Oligosaccharides Market, by Concentration
      • 8.2.4.6 Italy Human Milk Oligosaccharides Market
        • 8.2.4.6.1 Italy Human Milk Oligosaccharides Market, by Application
        • 8.2.4.6.2 Italy Human Milk Oligosaccharides Market, by Type
        • 8.2.4.6.3 Italy Human Milk Oligosaccharides Market, by Concentration
      • 8.2.4.7 Rest of Europe Human Milk Oligosaccharides Market
        • 8.2.4.7.1 Rest of Europe Human Milk Oligosaccharides Market, by Application
        • 8.2.4.7.2 Rest of Europe Human Milk Oligosaccharides Market, by Type
        • 8.2.4.7.3 Rest of Europe Human Milk Oligosaccharides Market, by Concentration
  • 8.3 Asia Pacific Human Milk Oligosaccharides Market
    • 8.3.1 Asia Pacific Human Milk Oligosaccharides Market, by Application
      • 8.3.1.1 Asia Pacific Infant Formula Market, by Country
      • 8.3.1.2 Asia Pacific Functional Food & Beverages Market, by Country
      • 8.3.1.3 Asia Pacific Food Supplements Market, by Country
      • 8.3.1.4 Asia Pacific Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
    • 8.3.2 Asia Pacific Human Milk Oligosaccharides Market, by Type
      • 8.3.2.1 Asia Pacific 2'FL Market, by Country
      • 8.3.2.2 Asia Pacific 3'FL Market, by Country
      • 8.3.2.3 Asia Pacific 3'SL Market, by Country
      • 8.3.2.4 Asia Pacific 6'SL Market, by Country
    • 8.3.3 Asia Pacific Human Milk Oligosaccharides Market, by Concentration
      • 8.3.3.1 Asia Pacific Neutral Market, by Country
      • 8.3.3.2 Asia Pacific Acidic Market, by Country
    • 8.3.4 Asia Pacific Human Milk Oligosaccharides Market, by Country
      • 8.3.4.1 China Human Milk Oligosaccharides Market
        • 8.3.4.1.1 China Human Milk Oligosaccharides Market, by Application
        • 8.3.4.1.2 China Human Milk Oligosaccharides Market, by Type
        • 8.3.4.1.3 China Human Milk Oligosaccharides Market, by Concentration
      • 8.3.4.2 Japan Human Milk Oligosaccharides Market
        • 8.3.4.2.1 Japan Human Milk Oligosaccharides Market, by Application
        • 8.3.4.2.2 Japan Human Milk Oligosaccharides Market, by Type
        • 8.3.4.2.3 Japan Human Milk Oligosaccharides Market, by Concentration
      • 8.3.4.3 India Human Milk Oligosaccharides Market
        • 8.3.4.3.1 India Human Milk Oligosaccharides Market, by Application
        • 8.3.4.3.2 India Human Milk Oligosaccharides Market, by Type
        • 8.3.4.3.3 India Human Milk Oligosaccharides Market, by Concentration
      • 8.3.4.4 South Korea Human Milk Oligosaccharides Market
        • 8.3.4.4.1 South Korea Human Milk Oligosaccharides Market, by Application
        • 8.3.4.4.2 South Korea Human Milk Oligosaccharides Market, by Type
        • 8.3.4.4.3 South Korea Human Milk Oligosaccharides Market, by Concentration
      • 8.3.4.5 Australia & New Zealand Human Milk Oligosaccharides Market
        • 8.3.4.5.1 Australia & New Zealand Human Milk Oligosaccharides Market, by Application
        • 8.3.4.5.2 Australia & New Zealand Human Milk Oligosaccharides Market, by Type
        • 8.3.4.5.3 Australia & New Zealand Human Milk Oligosaccharides Market, by Concentration
      • 8.3.4.6 Malaysia Human Milk Oligosaccharides Market
        • 8.3.4.6.1 Malaysia Human Milk Oligosaccharides Market, by Application
        • 8.3.4.6.2 Malaysia Human Milk Oligosaccharides Market, by Type
        • 8.3.4.6.3 Malaysia Human Milk Oligosaccharides Market, by Concentration
      • 8.3.4.7 Rest of Asia Pacific Human Milk Oligosaccharides Market
        • 8.3.4.7.1 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Application
        • 8.3.4.7.2 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Type
        • 8.3.4.7.3 Rest of Asia Pacific Human Milk Oligosaccharides Market, by Concentration
  • 8.4 LAMEA Human Milk Oligosaccharides Market
    • 8.4.1 LAMEA Human Milk Oligosaccharides Market, by Application
      • 8.4.1.1 LAMEA Infant Formula Market, by Country
      • 8.4.1.2 LAMEA Functional Food & Beverages Market, by Country
      • 8.4.1.3 LAMEA Food Supplements Market, by Country
      • 8.4.1.4 LAMEA Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
    • 8.4.2 LAMEA Human Milk Oligosaccharides Market, by Type
      • 8.4.2.1 LAMEA 2'FL Market, by Country
      • 8.4.2.2 LAMEA 3'FL Market, by Country
      • 8.4.2.3 LAMEA 3'SL Market, by Country
      • 8.4.2.4 LAMEA 6'SL Market, by Country
    • 8.4.3 LAMEA Human Milk Oligosaccharides Market, by Concentration
      • 8.4.3.1 LAMEA Neutral Market, by Country
      • 8.4.3.2 LAMEA Acidic Market, by Country
    • 8.4.4 LAMEA Human Milk Oligosaccharides Market, by Country
      • 8.4.4.1 Brazil Human Milk Oligosaccharides Market
        • 8.4.4.1.1 Brazil Human Milk Oligosaccharides Market, by Application
        • 8.4.4.1.2 Brazil Human Milk Oligosaccharides Market, by Type
        • 8.4.4.1.3 Brazil Human Milk Oligosaccharides Market, by Concentration
      • 8.4.4.2 Argentina Human Milk Oligosaccharides Market
        • 8.4.4.2.1 Argentina Human Milk Oligosaccharides Market, by Application
        • 8.4.4.2.2 Argentina Human Milk Oligosaccharides Market, by Type
        • 8.4.4.2.3 Argentina Human Milk Oligosaccharides Market, by Concentration
      • 8.4.4.3 UAE Human Milk Oligosaccharides Market
        • 8.4.4.3.1 UAE Human Milk Oligosaccharides Market, by Application
        • 8.4.4.3.2 UAE Human Milk Oligosaccharides Market, by Type
        • 8.4.4.3.3 UAE Human Milk Oligosaccharides Market, by Concentration
      • 8.4.4.4 Saudi Arabia Human Milk Oligosaccharides Market
        • 8.4.4.4.1 Saudi Arabia Human Milk Oligosaccharides Market, by Application
        • 8.4.4.4.2 Saudi Arabia Human Milk Oligosaccharides Market, by Type
        • 8.4.4.4.3 Saudi Arabia Human Milk Oligosaccharides Market, by Concentration
      • 8.4.4.5 South Africa Human Milk Oligosaccharides Market
        • 8.4.4.5.1 South Africa Human Milk Oligosaccharides Market, by Application
        • 8.4.4.5.2 South Africa Human Milk Oligosaccharides Market, by Type
        • 8.4.4.5.3 South Africa Human Milk Oligosaccharides Market, by Concentration
      • 8.4.4.6 Nigeria Human Milk Oligosaccharides Market
        • 8.4.4.6.1 Nigeria Human Milk Oligosaccharides Market, by Application
        • 8.4.4.6.2 Nigeria Human Milk Oligosaccharides Market, by Type
        • 8.4.4.6.3 Nigeria Human Milk Oligosaccharides Market, by Concentration
      • 8.4.4.7 Rest of LAMEA Human Milk Oligosaccharides Market
        • 8.4.4.7.1 Rest of LAMEA Human Milk Oligosaccharides Market, by Application
        • 8.4.4.7.2 Rest of LAMEA Human Milk Oligosaccharides Market, by Type
        • 8.4.4.7.3 Rest of LAMEA Human Milk Oligosaccharides Market, by Concentration

Chapter 9. Company Profiles

  • 9.1 Inbiose NV
    • 9.1.1 Company Overview
    • 9.1.2 SWOT Analysis
  • 9.2 Biosynth AG
    • 9.2.1 Company Overview
    • 9.2.2 SWOT Analysis
  • 9.3 Dextra Laboratories Ltd (ICE S.p.A)
    • 9.3.1 Company Overview
  • 9.4 Koninklijke DSM N.V.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Trials and Approvals:
      • 9.4.5.2 Acquisition and Mergers:
    • 9.4.6 SWOT Analysis
  • 9.5 BASF SE
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Product Launches and Product Expansions:
    • 9.5.1 SWOT Analysis
  • 9.6 Chr. Hansen Holding A/S
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segment & Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Trials and Approvals:
      • 9.6.5.2 Acquisition and Mergers:
  • 9.7 DuPont de Nemours, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
    • 9.7.6 SWOT Analysis
  • 9.8 Nestle S.A
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Product Launches and Product Expansions:
    • 9.8.6 SWOT Analysis
  • 9.9 Abbott Laboratories
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Product Launches and Product Expansions:
    • 9.9.6 SWOT Analysis
  • 9.10. Royal FrieslandCampina N.V.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Partnerships, Collaborations, and Agreements:
      • 9.10.5.2 Trials and Approvals:
    • 9.10.6 SWOT Analysis

Chapter 10. Winning Imperatives for Human Milk Oligosaccharides Market